Hybrid Brow Lift Study Tests Whether Ligament Release Can Prolong Thread Suspension
A planned prospective study in Türkiye is taking aim at a familiar problem in aesthetic eyelid surgery: barbed thread brow suspension can raise the lateral brow, but the lift may soften as tissue tension reasserts itself. Investigators at Goztepe Prof. Dr. Suleyman Yalcin City Hospital plan to test whether a limited release of the lateral brow-retaining ligaments, performed through an upper blepharoplasty incision, can make that elevation last longer without adding a meaningful safety penalty.
The concept is mechanically straightforward. Thread suspension can reposition the brow, but the lateral brow is not suspended in empty space; it is tethered by fibrous attachments and neighboring soft tissue planes that resist upward displacement. Releasing part of that restraint before placing the thread could improve mobilization of the brow tail and reduce the recoil that undermines durability over time.
Three Surgical Paths, One Question About Durability
The trial plans to enroll 90 adults between 20 and 70 years of age, with roughly 30 participants in each of three arms. One group will undergo standard upper blepharoplasty alone. A second will receive standard barbed thread brow suspension alone. The third will undergo the hybrid approach: upper blepharoplasty combined with limited release of the lateral retaining ligaments and barbed thread brow suspension.
Allocation will not be random. Instead, treatment will be selected on the basis of anatomical characteristics, clinical findings, and the patient’s surgical needs. That makes the study more reflective of day-to-day reconstructive and aesthetic practice, but it also introduces the usual risk of baseline imbalance between groups. Patients are not being treated as interchangeable surgical units; the operation is being matched to the face in front of the surgeon.
The study population centers on adults with brow ptosis, eyebrow descent, upper eyelid dermatochalasis, or age-related periorbital soft-tissue change. Exclusion criteria are broad enough to remove obvious sources of confounding: prior brow-lifting surgery, previous surgery in the forehead or periorbital area that could alter anatomy, facial paralysis, neuromuscular disorders, active infection, uncontrolled systemic disease, bleeding risk, pregnancy, breastfeeding, hypersensitivity to materials or local anesthetics, and inability to attend follow-up.
Photogrammetry Will Track Brow Position Over 12 Months
The primary endpoint is the change in lateral eyebrow height at 12 months compared with baseline. Investigators will measure that outcome with standardized digital photography and ImageJ software, a practical choice for a surgical question where small positional differences can matter. Brow symmetry, early and late complications, adverse events, and the need for revision surgery will be recorded as secondary outcomes.
Follow-up is planned at week 1 and at months 1, 3, 6, and 12 after surgery. That schedule should capture both the immediate postoperative effect and the slower drift that can follow in thread-based lifting procedures. Early postoperative swelling can temporarily exaggerate lift, while later relaxation of the soft tissue envelope may reveal whether the hybrid approach truly preserves the correction.
A single sentence captures the trial’s central wager: if the lateral attachments are the enemy of durable brow elevation, then releasing them should improve the odds of maintaining the result.
Why the Hybrid Approach Could Matter in Periorbital Aging
Periorbital aging rarely involves one isolated structure. The lateral brow drops, the upper lid skin redundancy increases, and the relationship between the eyelid crease and brow position changes in tandem. A conventional upper blepharoplasty may improve lid heaviness, but it does not directly address brow descent. Thread suspension, by contrast, attempts to elevate the brow without the tissue dissection of more extensive brow surgery, but its staying power may be limited if the underlying ligamentous restraint remains intact.
The hybrid procedure attempts to bridge those two strategies. Upper blepharoplasty provides direct access to the upper periorbital region, while limited release of the lateral brow-retaining ligaments may reduce the force opposing brow elevation. In theory, that could allow the barbed poly(L-lactide-co-epsilon-caprolactone) threads to hold the brow in a more favorable position for longer.
The biological logic is credible, but the procedure still has to prove itself where it matters most: in postoperative durability, not just immediate lift.
Safety, Symmetry, and Revision Need Will Decide the Value of the Technique
The investigators are not only looking for a higher brow arc at 12 months. They also plan to examine whether the hybrid approach preserves right-left symmetry, limits complications, and avoids the downstream need for revision surgery. Those are the details that determine whether a technique earns a place in surgical practice. A procedure that lifts well but creates asymmetry, wound problems, or recurrent ptosis would fail its most practical test.
Because this is an open-label, single-center, non-randomized study, any signal of benefit will need careful interpretation. The three arms may differ in baseline anatomy, the extent of dermatochalasis, and the degree of brow descent. Still, the design mirrors how aesthetic and reconstructive decisions are often made in real clinics, where surgical planning is driven by contour, tissue quality, and the pattern of aging rather than by a randomization envelope.
The chosen device is a CE-marked, double-needle, barbed PLACL thread, which places the study squarely within contemporary minimally invasive brow lifting practice. The question is whether the thread can do more if the surrounding tethering is partially released first.
What This Study Can and Cannot Answer Yet
The study is scheduled to start in late October 2026, with primary completion and full completion both estimated for January 2028. Until those data arrive, the trial remains a hypothesis-driven comparison rather than a proof of superiority. It may clarify whether hybrid brow elevation produces a more stable lateral brow position over 12 months than thread suspension alone, and whether any added tissue release introduces new complications.
What it cannot yet tell surgeons is whether the benefit, if one appears, will generalize beyond a single center or beyond the specific anatomy selected for this protocol. Non-randomized allocation and a relatively modest sample size also limit how confidently any difference can be attributed to the procedure itself. Those limitations are built into the design and will need to sit beside any efficacy signal when the first results are released.
For now, the study represents a focused attempt to solve a familiar cosmetic problem with a more anatomical operation: lift the brow, release the restraints, and see whether the correction holds when the early postoperative swelling is long gone.